Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
Netherlands Antilles
(0/week)
View all
(0/week)
News
United States
(1224/week)
Manufacturing
(557/week)
Technology
(1164/week)
Energy
(395/week)
Other Manufacturing
(379/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Blood proteins
May 27, 2020
Bio Products Laboratory Announces Launch of ALBUMINEX® 5% and ALBUMINEX® 25% With Supply Immediately Available in the United States
Jan 09, 2019
Protagonist Therapeutics Initiates Phase 2 Trial of Novel Hepcidin Mimetic PTG-300 for the Treatment of Patients with Beta Thalassemia
Dec 21, 2018
CytRx Corporation Announces Conclusion of Pre-Clinical Phase for Its Albumin Binding Ultra High Potency LADR(TM) Drug Candidates and Accompanying Companion Diagnostic
Nov 21, 2018
Albumin Market to Reach $10.31 Bn, Globally, by 2023 at 9.6% CAGR, Says Allied Market Research
Oct 31, 2018
Stellar Biotechnologies to Present at BlueTech Summit
Sep 05, 2018
Stellar Biotechnologies to Supply KLH to National Institutes of Health
Jul 05, 2018
Stellar Issues Statement on Favorable Clinical Study Results
Jun 21, 2018
Stellar Reports Positive Research Results from KLH Glycosylation Study
Jun 18, 2018
Protagonist Announces Phase 1 and Pre-clinical Data on Hepcidin Mimetic PTG-300 Presented at European Hematology Association Annual Meeting
May 24, 2018
Stellar Achieves Robust Viral Clearance for Manufacturing Process
May 17, 2018
Protagonist Therapeutics Announces Two Oral Presentations Accepted for 23rd Congress of the European Hematology Association
May 10, 2018
Global Plasma Fractionation Market 2018-2028 - Visiongain Report
Apr 09, 2018
CytRx Corporation to Present Breakthrough Data on Albumin Binding Ultra High Potency LADR(TM) Drug Candidates at the AACR 2018 Conference
Feb 16, 2018
Global Amyloidosis Market Spotlight 2017: Pfizer has Carried Out the Most Phase III Trials in Amyloidosis, Followed by Alnylam
Dec 14, 2017
Protagonist Therapeutics Announces Final Phase 1 Study Results with Novel Hepcidin Mimetic, PTG-300
Sep 25, 2017
Sonnet Biotherapeutics to present data on bispecific platform candidates at AACR and SITC Annual Meetings
Sep 07, 2017
St. Teresa Medical Announces First Commercial Use of SURGICLOT® in Auckland, New Zealand
Jul 27, 2017
Albumin Market Worth US$10.359 Billion by 2025: Keen Players Partner With Distributors to Bolster Position Says TMR
Jun 07, 2017
Stellar Biotechnologies Expands Operations Team
Latest News
Jun 4, 2025
BCforward Deepens AI Capabilities with a Major Strategic Investment in Stellar
Jun 4, 2025
Glenfarne Announces Over $115 Billion of Strategic Partner Interest for Alaska LNG
Jun 4, 2025
Tractor Supply Welcomes Lincoln Electric to Its Top-Tier Welding Lineup
Jun 4, 2025
FlexGen and Rosendin Partner to Deliver First-of-its-Kind Battery Storage Solution for Data Centers
Jun 4, 2025
Green Oceans Report Reveals Systematic Non-Compliance in Offshore Wind Development
Jun 4, 2025
Westinghouse eVinci® Test Reactor First to Receive Approval for Preliminary Safety Design Report
Jun 4, 2025
Climate Control Group Appoints Daniel Ellis as Chief Executive Officer
Jun 4, 2025
Optronics Gives Vehicle Branding Room to Glow with 4-Inch Round STL104 Series Custom LED Logo Lights
View all News
Agenda
30
September
Portugal
Troia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United Kingdom
London, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events